Science and Engineering Ethics 11 (1) (2005)
|Abstract||Remaining important tasks in finding and developing new drugs and vaccines for HIV/AIDS, malaria, cancer and other diseases require continued industry research and development. Industry’s research and development pipeline has produced drugs that have saved AIDS victims previously facing certain death, but still no cure nor vaccine is yet available. Experience with the process of research and development indicates that it requires more than a decade of development to produce a new drug with costs in the hundreds of millions of dollars. Intellectual property protection is critically important in assuring that drug development continues. Partnerships between industry and the public sector have increased access to new therapies in developing countries and promise to enhance access to both patented and generic medicines in the future.|
|Keywords||No keywords specified (fix it)|
|Through your library||Configure|
Similar books and articles
Shaili Jain (2007). Understanding Physician-Pharmaceutical Industry Interactions. Cambridge University Press.
Raymond Spier (1995). Ethical Aspects of the University-Industry Interface. Science and Engineering Ethics 1 (2).
Morgan P. Miles, Linda S. Munilla & Jeffrey G. Covin (2002). The Constant Gardener Revisited: The Effect Ofsocial Blackmail on the Marketing Concept,Innovation, and Entrepreneurship. Journal of Business Ethics 41 (3):287 - 295.
Edward R. Balotsky (2009). Where Strategy and Ethics Converge: Pharmaceutical Industry Pricing Policy for Medicare Part D Beneficiaries. Journal of Business Ethics 84:75 - 88.
Eva Turner (2001). The Case for Responsibility of the IT Industry to Promote Equality for Women in Computing. Science and Engineering Ethics 7 (2).
Sigrid Sterckx (forthcoming). Patenting and Licensing of University Research: Promoting Innovation or Undermining Academic Values? Science and Engineering Ethics.
Matthias Adam (2005). Integrating Research and Development: The Emergence of Rational Drug Design in the Pharmaceutical Industry. Studies in History and Philosophy of Science Part C 36 (3):513-537.
Richard T. de George (2005). Intellectual Property and Pharmaceutical Drugs. Business Ethics Quarterly 15 (4):549-575.
Raymond E. Spier (1998). Ethics and the Funding of Research and Development at Universities. Science and Engineering Ethics 4 (3):375-384.
Włodzimierz Kubiak (2005). Medicine and Pharmacy — Facts and Myths About the Development of an Innovative Pharmaceutical Industry in Poland. Science and Engineering Ethics 11 (1).
Added to index2009-01-28
Total downloads4 ( #178,675 of 549,084 )
Recent downloads (6 months)0
How can I increase my downloads?